HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.

Abstract
Elderly people and patients with comorbidities are at higher risk of COVID-19 infection, resulting in severe complications and high mortality. However, the underlying mechanisms are unclear. In this study, we investigate whether miRNAs in serum exosomes can exert antiviral functions and affect the response to COVID-19 in the elderly and people with diabetes. First, we identified four miRNAs (miR-7-5p, miR-24-3p, miR-145-5p and miR-223-3p) through high-throughput sequencing and quantitative real-time PCR analysis, that are remarkably decreased in the elderly and diabetic groups. We further demonstrated that these miRNAs, either in the exosome or in the free form, can directly inhibit S protein expression and SARS-CoV-2 replication. Serum exosomes from young people can inhibit SARS-CoV-2 replication and S protein expression, while the inhibitory effect is markedly decreased in the elderly and diabetic patients. Moreover, three out of the four circulating miRNAs are significantly increased in the serum of healthy volunteers after 8-weeks' continuous physical exercise. Serum exosomes isolated from these volunteers also showed stronger inhibitory effects on S protein expression and SARS-CoV-2 replication. Our study demonstrates for the first time that circulating exosomal miRNAs can directly inhibit SARS-CoV-2 replication and may provide a possible explanation for the difference in response to COVID-19 between young people and the elderly or people with comorbidities.
AuthorsYanbo Wang, Xiaoju Zhu, Xia-Ming Jiang, Jingwei Guo, Zheng Fu, Zhen Zhou, Ping Yang, Hongyuan Guo, Xu Guo, Gaoli Liang, Ping Zeng, Gengfu Xiao, Jizheng Ma, Xin Yin, Lei-Ke Zhang, Chao Yan, Chen-Yu Zhang
JournalSignal transduction and targeted therapy (Signal Transduct Target Ther) Vol. 6 Issue 1 Pg. 300 (08 11 2021) ISSN: 2059-3635 [Electronic] England
PMID34381015 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021. The Author(s).
Chemical References
  • Circulating MicroRNA
  • MIRN145 microRNA, human
  • MIRN223 microRNA, human
  • MIRN24 microRNA, human
  • MIRN7 microRNA, human
  • MicroRNAs
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
Topics
  • Adult
  • Age Factors
  • Aged
  • COVID-19 (blood, genetics, pathology, virology)
  • China
  • Circulating MicroRNA (blood, genetics)
  • Cohort Studies
  • Diabetes Mellitus (blood, genetics, pathology, virology)
  • Exercise
  • Exosomes (genetics, metabolism, virology)
  • Female
  • Gene Expression Regulation
  • HEK293 Cells
  • Host-Pathogen Interactions (genetics)
  • Humans
  • Male
  • MicroRNAs (blood, genetics)
  • Middle Aged
  • SARS-CoV-2 (genetics, growth & development, metabolism)
  • Spike Glycoprotein, Coronavirus (blood, genetics)
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: